Drug innovation traditionally follows a de novo approach with new molecules through a
complex preclinical and clinical pathway. In addition to this strategy, drug repositioning has …

Hyperinflammatory response caused by infections such as Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) increases organ failure, intensive care unit …

Drug repurposing, identifying FDA-approved drugs for new indications, reduces the time and
money required for a drug to reach the clinic and capitalizes on the increasing number of …